Where is Cellvec located?

Cellvec is headquartered in Singapore, Singapore.

Which legal entities is Cellvec associated with?

Cellvec is associated with CellVec Pte. Ltd..

How many employees does Cellvec have?

As of Apr 30, 2026, the latest employee count at Cellvec is 26.

Is Cellvec a funded company?

Cellvec is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Cellvec rank among its competitors?

Cellvec ranks 12th amongst 61 active competitors, of which 6 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Anthology, which secured an undisclosed amount in Jan, 2023.

Who are the top competitors of Cellvec?

Cellvec's top competitors include Strateos, Leveragen and SciGenom. Among them, Anthology secured the most recent funding round in January, 2023.

Cellvec - 2026 Company Profile, Team, Competitors & Financials

Company Details

Cellvec is a gene therapy contract development and manufacturing organization. It provides services like custom viral vectors for pre-clinical and clinical applications, fully functioning recombinant lentiviral vector contract manufacturing service to GMP standards, quality assurance, develop gene transfer producer system, develop molecular, expression construct, develop up-scale technologies, and purification and concentration process.

Website: cellvec.com
Phone Number: +65 **********

Key Metrics

Founded Year

2018

Location

Singapore, Singapore

Stage

Unfunded

Ranked

12^th among 61 active competitors

Employee Count

26 as on Apr 30, 2026

Similar Companies

Strateos & 75 more

View Cellvec's full profile

Cellvec is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CellVec Pte. Ltd. CIN: 201827204R , Singapore, Active	Aug 07, 2018	-	-

Cellvec has not raised any funding rounds yet.

The founders of Cellvec is Lucas Chan.

Here are the details of Cellvec's key team members:

Lucas Chan: Co-Founder & CSO of Cellvec.

Cellvec's Board of Directors

Cellvec's board has 3 active members. TEO CHENG PENG, Leong See Odd and Ang Peng Tiam are independent board members.

Here is the list of Cellvec's board of directors:

Name	Type	Representing	Status	Duration
mxztxjj	Team	-	Past	4y 2m
TEO CHENG PENG	Independent board member	-	Current	7y 9m
byqubmo	Independent board member	-	Current	7y 8m
estndff	Independent board member	-	Current	3y 7m
g{wexjd	Independent board member	-	Past	6y 2m
nyfclxs	Independent board member	-	Past	4y 4m

View details of Cellvec's Founder profiles and Board Members

Cellvec's employee count trend

Cellvec has 26 employees as of Apr 26. Here is Cellvec's employee count trend over the years:

Uncover Cellvec's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellvec include Strateos, Leveragen and SciGenom. Here is the list of Top 10 competitors of Cellvec, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strateos 2019, Menlo Park (United States), Series B	Provider of cloud based platform provides data driven information for biotech research	$72.6M	DCVC, Lux Capital & 18 others	44/100
2nd	Leveragen 2017, Cambridge (United States), Funding Raised	Provider of customised genetic engineering services	-	Massachusetts Biomedical Initiatives	40/100
3rd	SciGenom 2009, Kochi (India), Seed	Provider of genome sequencing and bioinformatics services life science and healthcare sector	$364K	Department of Biotechnology, BIRAC & 5 others	40/100
4th	Anthology 2023, Cambridge (United States), Seed	Biomanufacturing company that generates diverse genomes to scale and digitalize the industry	-	Climate Capital, Engine Ventures & 2 others	38/100
5th	Seevix 2014, Jerusalem (Israel), Seed	Genetically engineered spider silk fiber is a functional material for multiple industries	-	ASICS Corporation, Cashline Investment Holding ... & 1 others	33/100
6th	Lifeprint 2013, Illertissen (Germany), Unfunded	Genomic technology service provider	-	-	33/100
7th	Komo Biosciences 2024, United States, Unfunded	Provider of next-generation precision genome engineering technology for development and manufacturing of therapeutics	-	-	32/100
8th	Anapa Biotech 2002, Hvidovre (Denmark), Series A	Molecular tools to enhance the nucleic acids in PCR-based assays	$1M	Borean Innovation, Vecata	29/100
9th	Celther 2008, Lodz (Poland), Unfunded	Provider of primary cell line products and preclinical contract services	-	-	28/100
10th	Helix BioGenesis 2014, Noida (India), Unfunded	Provider of contract research and other genomic services	-	-	28/100
12th	Cellvec 2018, Singapore (Singapore), Unfunded	Gene therapy contract development and manufacturing organization	-	-	28/100